Association Between Very Low Levels of High‐Density Lipoprotein Cholesterol and Long‐term Outcomes of Patients With Acute Coronary Syndrome Treated Without Revascularization: Insights From the TRILOGY ACS Trial
ConclusionsMedically managed ACS patients with very low baseline HDL‐C levels have higher risk of long‐term cardiovascular and all‐cause death but similar risks for nonfatal ischemic outcomes vs patients with higher baseline HDL‐C.
Source: Clinical Cardiology - Category: Cardiology Authors: Emil Hagström, Matthew T. Roe, Gail Hafley, Megan L. Neely, Mandeep S. Sidhu, Kenneth J. Winters, Dorairaj Prabhakaran, Harvey D. White, Paul W. Armstrong, Keith A.A. Fox, E. Magnus Ohman, William E. Boden, Tags: Clinical Investigations Source Type: research
More News: Aspirin | Cardiology | Cardiovascular | Cholesterol | Clopidogrel | Heart | Heart Attack | Ischemic Stroke | Plavix | Stroke | Study